Skip to content
HowShorted

Accendra Health, Inc. short interest in 2020

In 2020, Accendra Health, Inc.'s disclosed short interest ran from 18.23% of shares outstanding on 15 Jan 2020 to 8.24% on 31 Dec 2020, a change of -9.99 percentage points. The year's high was 21.97% on 29 May 2020 and its low 7.93% on 15 Dec 2020, averaging 15.89% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.14 days on 15 Jul 2020. Full history: Accendra Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accendra Health, Inc. in 2020

2020 in figures

Start of year
18.23% (15 Jan 2020)
End of year
8.24% (31 Dec 2020)
Change
-9.99 pp
High
21.97% (29 May 2020)
Low
7.93% (15 Dec 2020)
Average
15.89%
Highest days to cover
16.14 (15 Jul 2020)
SEC filings marked
11

Every report in 2020

Accendra Health, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202018.23%9.83
31 Jan 202018.72%6.07
14 Feb 202019.61%9.50
28 Feb 202021.72%6.73
13 Mar 202020.24%4.1310-K filed, results (8-K), results (8-K)
31 Mar 202016.34%2.82
15 Apr 202018.83%3.61
30 Apr 202021.63%6.62
15 May 202020.72%4.6210-Q filed, results (8-K)
29 May 202021.97%8.20
15 Jun 202021.55%10.00
30 Jun 202021.40%9.91
15 Jul 202020.72%16.14
31 Jul 202015.72%1.26results (8-K)
14 Aug 202013.79%3.36results (8-K), 10-Q filed
31 Aug 202011.95%6.79
15 Sep 202011.83%8.93
30 Sep 202011.93%2.43results (8-K)
15 Oct 202012.34%2.88
30 Oct 20208.68%7.41
13 Nov 20208.64%4.17results (8-K), 10-Q filed
30 Nov 20208.52%7.14
15 Dec 20207.93%5.52
31 Dec 20208.24%4.03

See also: Accendra Health, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.